Shares of athenahealth, Inc. (NASDAQ:ATHN) have earned a consensus rating of “Hold” from the twenty-eight ratings firms that are currently covering the company, Marketbeat.com reports. Three analysts have rated the stock with a sell rating, twelve have issued a hold rating and twelve have given a buy rating to the company. The average 1 year target price among brokers that have covered the stock in the last year is $150.00.
A number of analysts recently weighed in on the stock. Piper Jaffray Companies reaffirmed a “buy” rating and issued a $152.00 price objective on shares of athenahealth in a report on Friday, July 14th. BidaskClub cut shares of athenahealth from a “hold” rating to a “sell” rating in a report on Wednesday, July 12th. Citigroup Inc. reaffirmed a “buy” rating and issued a $186.00 price objective (up previously from $169.00) on shares of athenahealth in a report on Monday, July 24th. UBS AG reaffirmed a “positive” rating and issued a $175.00 price objective (up previously from $157.00) on shares of athenahealth in a report on Monday, July 24th. Finally, First Analysis cut shares of athenahealth from an “equal weight” rating to an “underweight” rating and increased their price objective for the stock from $99.00 to $125.00 in a report on Monday, July 24th.
Shares of athenahealth (NASDAQ ATHN) traded up 1.56% during mid-day trading on Friday, hitting $124.02. 845,853 shares of the stock traded hands. The stock has a market cap of $4.95 billion, a P/E ratio of 157.39 and a beta of 1.76. The firm’s 50 day moving average price is $131.05 and its 200-day moving average price is $129.70. athenahealth has a 12-month low of $90.11 and a 12-month high of $158.66.
athenahealth (NASDAQ:ATHN) last released its quarterly earnings data on Thursday, July 20th. The health services provider reported $0.51 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.39 by $0.12. athenahealth had a net margin of 2.80% and a return on equity of 6.91%. The business had revenue of $301.10 million for the quarter, compared to analysts’ expectations of $298.68 million. During the same quarter last year, the company earned $0.34 EPS. The company’s revenue for the quarter was up 15.0% compared to the same quarter last year. Analysts predict that athenahealth will post $1.91 earnings per share for the current year.
COPYRIGHT VIOLATION NOTICE: This report was posted by Transcript Daily and is the sole property of of Transcript Daily. If you are accessing this report on another website, it was illegally stolen and republished in violation of international copyright laws. The correct version of this report can be read at https://transcriptdaily.com/2017/10/08/athenahealth-inc-athn-given-consensus-rating-of-hold-by-analysts.html.
In other athenahealth news, SVP Jonathan D. Porter sold 422 shares of the firm’s stock in a transaction dated Friday, July 21st. The shares were sold at an average price of $154.00, for a total value of $64,988.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Brandon H. Hull sold 800 shares of the firm’s stock in a transaction dated Tuesday, August 1st. The stock was sold at an average price of $140.01, for a total transaction of $112,008.00. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 16,505 shares of company stock valued at $2,240,851. Insiders own 3.20% of the company’s stock.
Several institutional investors and hedge funds have recently made changes to their positions in the business. FMR LLC boosted its holdings in shares of athenahealth by 0.8% in the second quarter. FMR LLC now owns 5,975,119 shares of the health services provider’s stock worth $839,803,000 after buying an additional 47,341 shares during the period. Janus Henderson Group PLC acquired a new position in shares of athenahealth in the second quarter worth about $713,856,000. Morgan Stanley boosted its holdings in shares of athenahealth by 9.7% in the first quarter. Morgan Stanley now owns 4,514,305 shares of the health services provider’s stock worth $508,717,000 after buying an additional 397,837 shares during the period. Vanguard Group Inc. boosted its holdings in shares of athenahealth by 1.8% in the second quarter. Vanguard Group Inc. now owns 3,100,643 shares of the health services provider’s stock worth $435,795,000 after buying an additional 53,361 shares during the period. Finally, Capital Research Global Investors boosted its holdings in shares of athenahealth by 15.5% in the second quarter. Capital Research Global Investors now owns 2,041,714 shares of the health services provider’s stock worth $286,963,000 after buying an additional 273,660 shares during the period.
athenahealth, Inc provides network-based medical record, revenue cycle, patient engagement, care coordination and population health services. The Company also offers Epocrates and other point-of-care mobile applications. The Company delivers majority of its service offerings through a single instance of cloud-based software, athenaNet.
Receive News & Ratings for athenahealth Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth Inc. and related companies with MarketBeat.com's FREE daily email newsletter.